Delivery Order SPE2DB22D9367-SPE2DB24FSY98

Award Date 7/24/24
Potential Completion Date 8/14/24
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) for use by the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract is a $46,732.08 firm fixed-price delivery order placed under a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which runs through December 31, 2025. Through this...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of various pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $18,568.80 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31, 2025....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) health facilities nationwide. The $11,089.08 firm fixed-price delivery order is issued under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency's Medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $18,397.58 to provide a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) through the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract is a firm fixed-price agreement with no set-aside designation, leveraging DMS Pharmaceutical Group's status as a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $74,135.50 firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, covers a comprehensive array of medications, including branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, a firm fixed-price delivery order worth $8,559.67, was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, a multi-year indefinite delivery contract...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $8,509.92 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order with a ceiling value of $11,840.00 and an ultimate completion date of April 25, 2024. It is part of a larger...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for a Prime Vendor Pharmaceutical program supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA). The $30,695.04 firm fixed-price delivery order covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical supplies....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $77,505.20 under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) program. The contract covers the supply of a diverse range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSY98
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $48,171.42 fixed-price delivery order contract covers a wide range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the Defense Logistics Agency (DLA) under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. The IDC allows the DLA to issue firm fixed-price delivery orders for pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group's status as a woman-owned small business enables it to secure direct awards for these pharmaceutical Prime Vendor programs without set-aside designations.

Generated 10/23/24, 9:48 AM